Work

Two-year ocular and developmental outcomes of a phase 1 dosing study of bevacizumab for retinopathy of prematurity

Year: 2022

Type: article

Study design: Clinical Trial

Source: Journal of American Association for Pediatric Ophthalmology and Strabismus

DOI: 10.1016/j.jaapos.2022.08.042

Authors: David K. Wallace, Amra Hercinovic, Sharon F. Freedman, Eric R. Crouch, Amit R. Bhatt, M. Elizabeth Hartnett, Michael B. Yang, David L. Rogers, Amy K. Hutchinson, William V. Good, Michael X. Repka, Raymond T. Kraker, Susan A. Cotter, Jonathan M. Holmes

Language: English

Topic: Retinopathy of Prematurity Studies

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4312939736

FWCI: 0.143

Cites:

Cited by: 1

Related to: 10